About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Rebound Hernia Repair Device Mesh Trial

NCT00968773·2 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Minnesota Medical Development, Inc.

With

University of Kentucky
Ohio State University

Age

18–80

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

18 to 80 years of age
Unilateral or bilateral inguinal hernia (moderate in size), primary in nature

You may not be if

Unable to provide informed consent
Assessed as ASA 3 or 4
Renal failure;creatinine greater than 2.0mg percent
Ascites as determined by clinical suspicion/ultrasound confirmation
Known pregnancy
Femoral hernias
Diabetes requiring injectable insulin
Prior lower abdominal surgery through lower midline or Pfannenstiel incision
TAPP approach
Requiring anticoagulants during surgery
Participation in another study involving another device or drug
Emergent procedures for hernia incarceration and strangulation
Recurrent inguinal hernias

The record

StatusUnknown

PhasePhase 4

Taking part70

StartedSep 2009

UpdatedMar 15, 2016

Conditions

Inguinal Hernia

Where2

University of Kentucky Dept. Of Surgery
Lexington, Kentucky, United States
The Ohio State Medical Center, Dept. of Surgery
Columbus, Ohio, United States

Clareo Health | Rebound Hernia Repair Device Mesh Trial